Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126589221 | 12658922 | 1 | I | 201604 | 20160815 | 20160817 | 20160817 | EXP | GB-DEXPHARM-20161764 | DEXCEL | 64.00 | YR | A | F | Y | 0.00000 | 20160817 | OT | GB | GB |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126589221 | 12658922 | 1 | PS | AMOXICILLIN. | AMOXICILLIN | 1 | DAILY DOSE: 1500 MG MILLGRAM(S) EVERY DAYS | 32937.5 | MG | U | 0 | 500 | MG | CAPSULE | TID | ||||
126589221 | 12658922 | 2 | SS | OMEPRAZOLE. | OMEPRAZOLE | 1 | DOES NOT TAKE EVERY DAY | U | 0 | 20 | MG | QD | |||||||
126589221 | 12658922 | 3 | C | ATORVASTATIN | ATORVASTATIN | 1 | DAILY DOSE: 40 MG MILLGRAM(S) EVERY DAYS | 0 | 40 | MG | TABLET | QD | |||||||
126589221 | 12658922 | 4 | C | CYCLIZINE | CYCLIZINE | 1 | UP TO THREE TIMES A DAY | 0 | 50 | MG | TABLET |
Indications of drugs used
no results found |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126589221 | 12658922 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126589221 | 12658922 | Tubulointerstitial nephritis |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126589221 | 12658922 | 1 | 20160310 | 20160517 | 0 | |
126589221 | 12658922 | 4 | 20160623 | 0 |